Innovative drug Tarceva® now available in Europe to tackle growing lung cancer epidemic

10/21/05

Lung cancer has become a global epidemic with 1.2 million people being diagnosed and 1.1 million people dying each year. There have been no significant improvements in the effectiveness of chemotherapy agents in the last ten years so new therapies, that can improve survival, are urgently needed.

WHAT:
Come and hear eminent experts in the field of lung cancer including, specialists, patient groups and patients themselves, discuss the economic impact and access to lung cancer care, the patient experience and Tarceva® an unprecedented improvement in the treatment of advanced lung cancer.

WHO:
Professor Nick Thatcher
CRC Department of Medical Oncology
Christie Hospital
Manchester, UK

Dr. Jesme Baird
Global Lung Cancer Coalition and Director of Patient Care, Roy Castle Lung Cancer
Foundation, Glasgow, UK

Professor Giuseppe Giaccone
VU Medical Center, Amsterdam
The Netherlands

Professor Bengt Jönsson, Ph.D
Professor in Health Economics, Stockholm
School of Economics and the Karolinska
Institute, Sweden

WHEN:
Monday, 31 October 2005 08:30 CET

WHERE:
Room 243, Level 2 Palais des Congrès de Paris
2, Place de la Porte Maillot
75017 Paris, France

MEDIA CONTACT AT ECCO CONGRESS:
Anthea Morris Resolute Communications
44-777-851-5543.

CONTACT OFFSITE:
Helen Bridges Resolute Communications
44-781-529-7112.

Source: Eurekalert & others

Last reviewed: By John M. Grohol, Psy.D. on 21 Feb 2009
    Published on PsychCentral.com. All rights reserved.

 

 

I do not think there is any other quality so essential to success of any kind as the quality of perseverance. It overcomes almost everything, even nature.
-- John D. Rockefeller